Lower urinary tract symptoms Urological and Genital Diseases
Conditions
Interventions
A cluster randomized controlled trial (RCT) was conducted in general practices in the Netherlands with a total patient population of 24,000. Randomization took place at GP level instead of at patient
Sponsors
Radboud University Nijmegen Medical Centre
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Patients aged 50 and older, who were consulting their GP with LUTS for the first time. LUTS were defined as ‘micturition problems not evidently explained by a specific condition’, in accordance with the definition found in the practice guideline of the Dutch College of General Practitioners
Exclusion criteria
Exclusion criteria: 1. Medication usage (alpha-blockers, 5-alpha-reductase inhibitors or anticholinergics) 2. Previous visits to a urologist because of LUTS 3. Diagnosed or suspected prostate cancer; and a diagnosed urinary tract infection, haematuria or other urologic pathology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients referred to urologists within 3 and within 12 months after first consultation measured using patient records | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Severity of the symptoms measured using IPSS and IPSS-QOL at baseline and one year of follow up 2. Patient satisfaction measured using a Likert scale of 1 to 5 (very dissatisfied to very satisfied) after one year of follow up 3. Urologic medication use (alpha-blocker or 5ARI) measured using patient questionnaire after one year of follow up | — |
Countries
Netherlands
Outcome results
None listed